selected scholarly activity
-
conferences
- Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo-controlled feasibility clinical trial. Surgery. 670-676. 2022
- Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo controlled feasibility clinical trial.. Journal of Clinical Oncology. 482-482. 2022
- 2021 Canadian Surgery Forum. Canadian Journal of Surgery. S80-S159. 2021
- LAPAROSCOPIC HEPATECTOMY IS SAFE AND EFFECTIVE FOR COLORECTAL LIVER METASTASES IN A POPULATION-BASED ANALYSIS INONTARIO, CANADA. Gastroenterology. S1492-S1492. 2020
- Simultaneous versus staged resection of rectal cancer and synchronous liver metastases (RESECT). European Surgery - Acta Chirurgica Austriaca. 8-15. 2020
- Cost Analysis of Simultaneous vs Staged Resection of Colorectal Cancer Liver Metastases: A Population Based Study. Journal of the American College of Surgeons. S56-S56. 2019
- Simultaneous resection of colorectal cancer with synchronous liver metastases: A survey-based analysis.. Journal of Clinical Oncology. 662-662. 2019
- Simultaneous versus staged resection for synchronous colorectal cancer liver metastases: A population-based cohort study.. Journal of Clinical Oncology. 665-665. 2019
- Major arterial resection for stage 3 adenocarcinoma of the pancreas.. Journal of Clinical Oncology. 362-362. 2018
- Systematic Review and Meta-Analysis of the Effect of Pre-Operative PET/PET-CT in the Management of Patients With Potentially Resectable Colorectal Cancer Liver Metastasis. Annals of Surgical Oncology. S124-S125. 2018
- Surgical Outcomes and Costs of Pancreaticoduodenectomy in Octogenarians. Gastroenterology. S1290-S1290. 2017
- Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Complete Resection? A Systematic Review and Meta-analysis. Annals of Surgical Oncology. S77-S77. 2017
- Does the addition of biologic agents to chemotherapy in patients with unresectable colorectal cancer metastases result in a higher proportion of patients undergoing resection? A systematic review and meta-analysis.. Journal of Clinical Oncology. 690-690. 2017
- Incidence of Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgery for Cancer. Annals of Surgical Oncology. S26-S26. 2017
- Su1393 Does Giving Pasireotide to Patients Undergoing Pancreaticoduodenectomy Pay for Itself?. Gastroenterology. S1211-S1211. 2016
- Impact of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas After Pancreaticoduodenectomy. Gastroenterology. S1091-S1091. 2014
- Clinico-Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas. Gastroenterology. S1105-S1105. 2013
- Risk-Benefit Assessment of the Use of Intraperitoneal Drainage After Pancreaticoduodenectomy. Gastroenterology. S1103-S1103. 2013
- Quality of Life in a Multi-enter Phase II Trial of Neoadjuvant Full Dose Gemcitabine, Oxaliplatin and Radiation in Patients with Resectable or Borderline Resectable Pancreatic Adenocarcinoma. Annals of Surgical Oncology. S32-S32. 2013
- Quality of life in a multicenter phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.. Journal of Clinical Oncology. 226-226. 2013
- Obesity is a risk factor for nosocomial infections in the trauma population. Journal of the American College of Surgeons. S104-S104. 2009
-
journal articles
- Comparing cefazolin/metronidazole, piperacillin‐tazobactam, or cefoxitin as surgical antibiotic prophylaxis in patients undergoing pancreaticoduodenectomy: A retrospective cohort study. Journal of Surgical Oncology. 129:1413-1419. 2024
- Quality of life following perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo‐controlled feasibility clinical trial. Journal of Surgical Oncology. 129:1289-1294. 2024
- Circumstances and implications of conversion from minimally invasive to open liver resection: a multi-center analysis from the AMILES registry. Surgical Endoscopy. 37:9201-9207. 2023
- Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome. Annals of Surgery. 278:e1041-e1047. 2023
- Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy. Journal of the American Medical Association (JAMA). 329:1579-1579. 2023
- Model to predict major complications following liver resection for HCC in patients with metabolic syndrome. Hepatology. 77:1527-1539. 2023
- Prediction of Postoperative Mortality in Patients With Organ Failure Following Pancreaticoduodenectomy. American Surgeon. 89:1519-1526. 2023
- Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study. EClinicalMedicine. 59:101951-101951. 2023
- Textbook outcomes and benchmarks of minimally invasive left lateral sectionectomy across North America. Surgical Endoscopy. 37:2980-2986. 2023
- Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases. Annals of Surgical Oncology. 30:1331-1338. 2023
- Use of population-based electronic databases for the identification of patients with synchronous colorectal cancer and liver metastases potentially eligible for a surgical trial. Canadian Journal of Surgery. 66:E52-E58. 2023
- Heterogeneity of management practices surrounding operable gallbladder cancer – results of the OMEGA-S international HPB surgical survey. HPB. 24:2006-2012. 2022
- Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. Journal of Surgical Oncology. 126:386-393. 2022
- Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study. Surgery. 172:234-240. 2022
- Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA network open. 5:e2222721-e2222721. 2022
- Prognostic factors of overall survival in patients with recurrent disease following liver resection for colorectal cancer metastases: A multicenter external validation study. Journal of Surgical Oncology. 125:872-879. 2022
- Weight Loss Following Hepatopancreatobiliary Surgery. How Much is Too Much? A Retrospective Cohort Study. Surgical Innovation. 29:195-202. 2022
- Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project. Journal of Surgical Oncology. 125:437-447. 2022
- Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial. Journal of Surgical Oncology. 125:671-677. 2022
- The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions. Nutrition Reviews. 80:215-229. 2022
- Frailty Predicts Postoperative Complications following Pancreaticoduodenectomy. European Surgical Research. 63:232-240. 2022
- PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to prevent post-operative pancreatic fistula following distal pancreatectomy. HPB. 24:72-78. 2022
- Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease. American Surgeon. 87:1431-1437. 2021
- Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations. Bladder Cancer. 7:261-278. 2021
- Postoperative pain after intrathecal analgesia in laparoscopic liver resection: a retrospective chart review. Minerva Anestesiologica. 87:856-863. 2021
- Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey. Surgery. 170:173-179. 2021
- Surgical Culture Shifts and Randomized Clinical Trials. JAMA network open. 4:e2115456-e2115456. 2021
- Pre-operative testing and personal protective equipment in the operating room during a pandemic: A survey of Ontario general surgeons. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 6:23-31. 2021
- ASO Author Reflections: Uptake of Surgical Innovations: More Evidence and Less Opinion and Enthusiasm. Annals of Surgical Oncology. 28:2692-2692. 2021
- Enthusiasm, Opinion Leaders, Comparative Advantage, and the Uptake Of Laparoscopic Resection For Colorectal Cancer Liver Metastases in Ontario, Canada: A Population-Based Cohort Study. Annals of Surgical Oncology. 28:2685-2691. 2021
- Frailty as a Predictor of Postoperative Morbidity and Mortality Following Liver Resection. American Surgeon. 87:648-654. 2021
- Incidence and predictors of splanchnic vein thrombosis and mortality following hepatobiliary and pancreatic surgery. Journal of Thrombosis and Haemostasis. 19:797-804. 2021
- A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey. Annals of Surgical Oncology. 28:1069-1078. 2021
- Laparoscopic hepatectomy is safe and effective for the management of patients with colorectal cancer liver metastases in a population-based analysis in Ontario, Canada. A retrospective cohort study. International Journal of Surgery. 83:47-52. 2020
- Does giving pasireotide to patients undergoing pancreaticoduodenectomy always pay for itself?. European Surgery - Acta Chirurgica Austriaca. 52:132-140. 2020
- Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cost analysis in Ontario, Canada - Health economic evaluation. International Journal of Surgery. 78:75-82. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:e16656-e16656. 2020
- Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial. Journal of Surgical Oncology. 121:1001-1006. 2020
- Simultaneous resection of colorectal cancer with synchronous liver metastases; a practice survey. HPB. 22:728-734. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:511-511. 2020
- Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study. International Journal of Surgery. 74:68-75. 2020
- Enteral Versus Parenteral Nutrition for Postoperative Pancreatic Fistula: A Systematic Review and Meta-analysis. Surgery, Gastroenterology and Oncology. 25:170-170. 2020
- Incidence of Splanchnic Vein Thrombosis After Abdominal Surgery: A Systematic Review and Meta-analysis. Journal of Surgical Research. 245:500-509. 2020
- Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. Journal of Surgical Oncology. 120:1420-1426. 2019
- Incidence of delayed venous thromboembolic events in patients undergoing abdominal and pelvic surgery for cancer: a systematic review and meta‐analysis. ANZ Journal of Surgery. 89:1217-1223. 2019
- A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases. European Journal of Surgical Oncology. 45:1341-1348. 2019
- Effect of Perioperative Nutritional Supplementation on Postoperative Complications—Systematic Review and Meta-Analysis. Journal of Gastrointestinal Surgery. 23:1682-1693. 2019
- Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis. Journal of Surgical Research. 239:14-21. 2019
- Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas. HPB. 21:643-652. 2019
- Simultaneous resection of colorectal cancer with synchronous liver metastases: A survey-based analysis.. Journal of Clinical Oncology. 37:e15073-e15073. 2019
- Simultaneous versus staged resection for synchronous colorectal cancer liver metastases: A population-based cohort study.. Journal of Clinical Oncology. 37:3612-3612. 2019
- Patient blood management for liver resection: consensus statements using Delphi methodology. HPB. 21:393-404. 2019
- Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review. Surgical Endoscopy. 33:366-376. 2019
- ASO Author Reflections: Post-Discharge Venous Thromboembolism Incidence and Risk Factors. Annals of Surgical Oncology. 25:745-746. 2018
- Postoperative complications in elderly patients following pancreaticoduodenectomy lead to increased postoperative mortality and costs. A retrospective cohort study. International Journal of Surgery. 60:204-209. 2018
- Perioperative Optimization With Nutritional Supplements in Patients Undergoing Gastrointestinal Surgery for Cancer (PROGRESS): Protocol for a Feasibility Randomized Controlled Trial. JMIR Research Protocols. 7:e10491-e10491. 2018
- Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study. Annals of Surgical Oncology. 25:3214-3221. 2018
- Herpes Simplex Virus Colitis in a Patient with Newly Diagnosed Crohn’s Disease. Case Reports in Medicine. 2018:1-3. 2018
- A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastasis.. Journal of Clinical Oncology. 36:3547-3547. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases).. Journal of Clinical Oncology. 36:3527-3527. 2018
- Perioperative Optimization With Nutritional Supplements in Patients Undergoing Gastrointestinal Surgery for Cancer (PROGRESS): Protocol for a Feasibility Randomized Controlled Trial (Preprint) 2018
- Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis. Journal of Gastrointestinal Surgery. 22:523-528. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases: The long-term results of a randomized control trial.. Journal of Clinical Oncology. 36:562-562. 2018
- Systematic review and meta-analysis of the effect of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis.. Journal of Clinical Oncology. 36:591-591. 2018
- Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study. International Journal of Surgery Protocols. 8:1-6. 2018
- Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis. American Journal of Tropical Medicine and Hygiene. 97:1214-1217. 2017
- Incidence of venous thromboembolic events following major pelvic and abdominal surgery for cancer.. Journal of Clinical Oncology. 35:478-478. 2017
- Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy. American Surgeon. 82:1187-1195. 2016
- Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial. Annals of Surgical Oncology. 23:2644-2651. 2016
- Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. JCO Oncology Practice. 12:e765-e774. 2016
- PET-CT compared to no PET-CT in the management of potentially resectable colorectal cancer liver metastases: The costs implications of a randomized controlled trial.. Journal of Clinical Oncology. 34:296-296. 2016
- Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis. Annals of Surgery. 261:1138-1144. 2015
- Improved Long-Term Outcomes After Resection of Pancreatic Adenocarcinoma: A Comparison Between Two Time Periods. Annals of Surgical Oncology. 22:1160-1167. 2015
- Risk factors associated with recurrence in patients with solid pseudopapillary tumors of the pancreas.. Journal of the Pancreas. 15:561-568. 2014
- Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma. International Journal of Radiation Oncology Biology Physics. 90:270-277. 2014
- Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortality. HPB. 16:797-800. 2014
- Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases. Journal of the American Medical Association (JAMA). 311:1863-1863. 2014
- Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases. HPB. 16:475-480. 2014
- Obesity as a Risk Factor for Nosocomial Infections in Trauma Patients. Journal of the American College of Surgeons. 211:61-67. 2010
-
theses